首页 | 本学科首页   官方微博 | 高级检索  
     


Tissue transglutaminase: An emerging target for therapy and imaging
Authors:Markus Pietsch  Robert Wodtke  Jens Pietzsch  Reik Löser
Affiliation:1. Institute of Pharmacology, University Hospital Cologne, Gleueler Straße 24, 50931 Köln, Germany;2. Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328 Dresden, Germany;3. Department of Chemistry and Food Chemistry, Technical University Dresden, Bergstraße 66c, 01062 Dresden, Germany
Abstract:Tissue transglutaminase (transglutaminase 2) is a multifunctional enzyme with many interesting properties resulting in versatile roles in both physiology and pathophysiology. Herein, the particular involvement of the enzyme in human diseases will be outlined with special emphasis on its role in cancer and in tissue interactions with biomaterials. Despite recent progress in unraveling the different cellular functions of transglutaminase 2, several questions remain. Transglutaminase 2 features in both confirmed and some still ambiguous roles within pathological conditions, raising interest in developing inhibitors and imaging probes which target this enzyme. One important prerequisite for identifying and characterizing such molecular tools are reliable assay methods to measure the enzymatic activity. This digest Letter will provide clarification about the various assay methods described to date, accompanied by a discussion of recent progress in the development of inhibitors and imaging probes targeting transglutaminase 2.
Keywords:Tissue transglutaminase (TGase 2)  Cancer  Biomaterial–tissue interface  Activity assays  Inhibitors  Imaging probes
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号